The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors

Madlen Gazarian and Karen I Kaye
Med J Aust 2002; 177 (10): . || doi: 10.5694/j.1326-5377.2002.tb04960.x
Published online: 18 November 2002

To the Editor: We agree that the "what", "how" and "who" of guideline development all deserve equal, explicit and systematic attention.1

  • Madlen Gazarian
  • Karen I Kaye



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.